| Name: | Fingolimod Palmitate Amide Impurity |
| Catalogue No. | VL1270005 |
| CAS No. | 1242271-26-6 |
| Molecular Formula | C₃₅H₆₃NO₃ |
| Molecular Weight | 545.88 |
| Status | In-stock |
| IUPAC Name | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)palmitamide |
| Appearance | White Powder |
| Description | Fingolimod Palmitate Amide Impurity (CAS No. 1242271-26-6) or N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)palmitamide is an impurity of Fingolimod. Fingolimod may be a sphingosine 1-phosphate receptor modulator wont to treat patients with the relapsing-remitting variety of disseminated multiple sclerosis (MS) and studied to manage respiratory organ complications of COVID-19. |
| References | “Sci-Hub | Fingolimod Treatment Promotes Regulatory Phenotype and Function of B Cells. Annals of Clinical and Translational Neurology, 2(2), 119–130 | 10.1002/Acn3.155.” Sci-Hub.se, 2015, sci-hub.se/onlinelibrary.wiley.com/doi/full/10.1002/acn3.155. |
